dsm-firmenich and Brains Bioceutical

Together, dsm-firmenich and Brains Bioceutical have created an innovation platform to enable agile, early drug development and partner with our customers to realize the full therapeutic potential of cannabinoid-based pharmaceuticals. We have the core competencies, combined with a deep understanding of patient and customer needs, to help brands enter the cannabinoid market with confidence, and develop therapies that will safely and efficiently improve people’s lives.